Only the beginning of precision medicine and multiple myeloma.
The future of lymphoma treatment – combining new therapies with molecular diagnosis
MURANO trial: revolutionizing the standard of care for relapsed CLL patients
Biosimilars - the question of trials and approval
Summary of CLL trials presented at ASH 2016